z-logo
open-access-imgOpen Access
Exploiting MET dysregulation in EGFR-addicted non-small-cell lung carcinoma: a further step toward personalized medicine
Author(s) -
Vincenzo Di Noia,
Ettore D’Argento,
Sara Pilotto,
Miriam Grazia Ferrara,
Michèle Milella,
Giampaolo Tortora,
Emilio Bria
Publication year - 2018
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2018.12.08
Subject(s) - medicine , epidermal growth factor receptor , lung cancer , tyrosine kinase , personalized medicine , protein tyrosine kinases , carcinoma , targeted therapy , cancer research , oncology , epidermal growth factor , bioinformatics , cancer , receptor , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom